Measles Market Trends And Growth Analysis By Type (Red Measles, German Measles), Treatment (Antibiotic, Antiviral, Vaccine (Mumps Measles Rubella, Varicella Virus, Live (Mmr-Ii) & Mumps Measles Rubella)), End User (Hospitals, Clinics, Other) – Global Forecast Till 2023
Measles Vaccine Market is Expected to Grow at a CAGR of ~5.1 % by 2023 :
Measles or rubeola is a contagious viral infection majorly affects the respiratory system. An infected person can release the pathogens into the air when they cough or sneeze. The main symptom of measles is an itchy skin rash. The rash often starts on the head and moves down the body. Other symptoms include: fever, cough, runny nose, and conjunctivitis. Measles is one of the leading causes of death in children. According to the World Health Organization (WHO), in 2014, 114,900 global deaths related to measles was reported and that most of the patients were under the age of 5. Increasing prevalence of the disease and changing lifestyle are the major drivers for the growth of the market. Moreover, increasing prevalence of immunological diseases and increasing government support for research & development have fuelled the market growth. However, high cost of the treatment may hinder the growth of the market over the review period.
The Americas account for a significant share of the market owing to the presence of huge patient population with various diseases. According to the Autoimmune Registry, in 2012, 14.7 million people in the US were suffering from autoimmune diseases. Auto immune diseases is one of the major factors responsible for measles. Additionally, high healthcare spending and increasing government support for research & development have fueled the market growth in this region.
The global measles market has been segmented on the basis of types, treatment, and end users.
On the basis of type, the market is segmented into red measles and German measles.
On the basis of treatment, the market is segmented into antibiotic treatment, antiviral treatment, vaccine, and others. Vaccines are further segmented into mumps measles rubella vaccine, live (MMR-II) & mumps measles rubella, and varicella virus vaccine (Proquad).
On the basis of end user, the market is segmented into hospital, clinics, and others.
Get full report @https://www.marketresearchfuture.com/reports/measles-market-4449
Some of key players profiled in the report are Abbott (US), Novartis AG (Switzerland), Biomedical diagnostics (US), Johnson & Johnson Services, Inc. (US), Sanofi (US), Merck & Co., Inc. (US), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), MedImmune (US Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (US), and GlaxoSmithKline plc (US), and others.
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.